SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 4:15 PM ETAbout this dataData status
$27.63▼-0.84 (-2.97%)
After Hours:$27.63+0.00 (+0.00%)· 4:15 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.9 · elevated volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

EBITDA

-$186.72M

TTM · Period ending: · USD

PBLS logo

PBLS EBITDA

Latest reported-$186.72M
PBLS EBITDA (-$114.33M → -$186.72M)
High-resolution chart · PNG

What is ebitda?

EBITDA is earnings before interest, taxes, depreciation and amortization. It is a measure of earnings, not cash flow.

Compare ebitda

PBLS ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Parabilis Medicines, Inc. EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
-141,867,000
-114,328,000

Frequently asked questions: PBLS ebitda

What is Parabilis Medicines, Inc. (PBLS)'s current ebitda?

Parabilis Medicines, Inc. (PBLS)'s latest reported ebitda (TTM) is -$186.72M as of Sep 30, 2026. EBITDA is earnings before interest, taxes, depreciation and amortization. It is a measure of earnings, not cash flow.

How much historical ebitda data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s ebitda, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's ebitda to peers or set an alert?

You can compare PBLS's ebitda directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.